School of Medical Equipment, Shenyang Pharmaceutical University, Shenyang 110016, China.
Liaoning Medical Big Data and Artificial Intelligence Engineering Technology Research Center, Shenyang 110016, China.
Int J Environ Res Public Health. 2020 May 26;17(11):3766. doi: 10.3390/ijerph17113766.
COVID-19 has become one of the most serious global epidemics in the 21st Century. This study aims to explore the distribution of research capabilities of countries, institutions, and researchers, and the hotspots and frontiers of coronavirus research in the past two decades. In it, references for funding support of urgent projects and international cooperation among research institutions are provided.
the Web of Science core collection database was used to retrieve the documents related to coronavirus published from 2003 to 2020. Citespace.5.6.R2, VOSviewer1.6.12, and Excel 2016 were used for bibliometric analysis.
11,036 documents were retrieved, of which China and the United States have contributed the most coronavirus studies, Hong Kong University being the top contributor. Regarding journals, the has contributed the most, while in terms of researchers, Yuen Kwok Yung has made the most contributions. The proportion of documents published by international cooperation has been rising for decades. Vaccines for SARS-CoV-2 are under development, and clinical trials of several drugs are ongoing.
international cooperation is an important way to accelerate research progress and achieve success. Developing corresponding vaccines and drugs are the current hotspots and research directions.
COVID-19 已成为 21 世纪最严重的全球传染病之一。本研究旨在探索过去 20 年来各国、各机构和研究人员的研究能力分布,以及冠状病毒研究的热点和前沿。文中提供了对紧急项目的资助支持和研究机构间国际合作的参考依据。
利用 Web of Science 核心合集数据库检索了 2003 年至 2020 年发表的与冠状病毒相关的文献。使用 Citespace.5.6.R2、VOSviewer1.6.12 和 Excel 2016 进行了文献计量分析。
共检索到 11036 篇文献,其中中国和美国对冠状病毒研究的贡献最大,香港大学是最主要的贡献者。就期刊而言,《柳叶刀》的贡献最大,而就研究人员而言,袁国勇的贡献最大。几十年来,国际合作发表的文献比例一直在上升。针对 SARS-CoV-2 的疫苗正在研发中,几种药物的临床试验正在进行。
国际合作是加速研究进展和取得成功的重要途径。开发相应的疫苗和药物是当前的热点和研究方向。